Posted by Michael Wonder on 24 Aug 2023
PMPRB report reveals most new medicines come to market with high treatment costs
22 August 2023 - The Patented Medicine Prices Review Board published today the 7th edition of its annual Meds Entry Watch report.
The analysis finds that the number of new medicines launched in Canada is higher than the median for Organisation for Economic Co-operation and Development countries but falls below the median of the eleven PMPRB comparators, all of which have lower average patented medicine prices according to the PMPRB's Annual Report, 2021.
